Dr. Romana Popara Dymkoski, DO

Dr. Dymkoski practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Dymkoski's NPI, 1235588260, was assigned on June 9, 2016. Dr. Dymkoski graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 2016. Dr. Dymkoski holds California license 20A16100.

Dr. Dymkoski's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Dymkoski's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Dymkoski to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dymkoski practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Dymkoski's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Dymkoski is board certified in consultation-liaison psychiatry by the American Board of Psychiatry and Neurology. Dr. Dymkoski is licensed in California.

Dmand AI lists adjustment disease, anxiety, depression and non-alzheimer's dementia (chronic) among the conditions Dr. Dymkoski treats.

CMS data shows 363 Medicare services from Dr. Dymkoski across 5 procedure codes in 2024, for 139 Medicare patients. Medicare paid $30,334 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 139 Medicare patients who saw Dr. Dymkoski in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have depression, and 75% have high blood pressure. 66% are also on Medicaid. Their average risk score is 3.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dymkoski's median patient age at 59, with 36% women.

In 2024, Dr. Dymkoski wrote 35 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $53 in total drug cost. In 2019, CMS named 74 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Dymkoski for performance year 2024, reported as part of a group. Dr. Dymkoski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dymkoski as offering telehealth.

CMS Open Payments shows 2 general payments to Dr. Dymkoski from 1 drug or device company from 2020 to 2021. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $47.

Dr. Dymkoski graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 2016.

Dr. Dymkoski is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.